FDA Inspection 1114117 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Nov 15, 2019 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 15, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Orlando, FL (United States)